Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02145039 · OUTCOME

Number of Patients Experiencing Chronic Graft-versus-host Disease by 1 Year

Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases · Source last updated 2019-12-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
1 year

Analysis population: Data were not collected for this Outcome Measure as both participants died by the 6 month time point

Groups in this outcome

Haploidentical Stem Cell Transplant

This is a treatment guideline for HLA-Haploidentical hematopoietic stem cell transplant (HSCT) using a reduced intensity conditioning (RIC) regimen. This regimen consists of fludarabine, cyclophosphamide and low dose total body irradiation (TBI). Fludarabine: Fludarabine 30 mg/m2 IV over 30-60 minutes on days -6 through -2 before transplant. Cyclophosphamide: Cyclophosphamide 14.5 mg/kg IV over 1-2 hours on days -6 and -5 before transplant and Cyclophosphamide 50 mg/kg IV on days 3 and 4 post-transplant. Total Body Irradiation: TBI 200cGy on day -1 before transplant. Haploidentical stem cell transplant: Non-T-cell depleted bone marrow infusion

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Haploidentical Stem Cell Transplant0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    units
    Participants
groups
  1. description
    This is a treatment guideline for HLA-Haploidentical hematopoietic stem cell transplant (HSCT) using a reduced intensity conditioning (RIC) regimen. This regimen consists of fludarabine, cyclophosphamide and low dose total body irradiation (TBI). Fludarabine: Fludarabine 30 mg/m2 IV over 30-60 minutes on days -6 through -2 before transplant. Cyclophosphamide: Cyclophosphamide 14.5 mg/kg IV over 1-2 hours on days -6 and -5 before transplant and Cyclophosphamide 50 mg/kg IV on days 3 and 4 post-transplant. Total Body Irradiation: TBI 200cGy on day -1 before transplant. Haploidentical stem cell transplant: Non-T-cell depleted bone marrow infusion
    id
    OG000
    title
    Haploidentical Stem Cell Transplant
population Description
Data were not collected for this Outcome Measure as both participants died by the 6 month time point
reporting Status
POSTED
time Frame
1 year
title
Number of Patients Experiencing Chronic Graft-versus-host Disease by 1 Year
type
SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice